vaxart's bivalent norovirus vaccine candidate has many broad advantages
Published 1 year ago • 336 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
0:20
totality of data to inform next steps for vaxart's norovirus vaccine candidate
-
0:25
data is promising for vaxart's oral norovirus vaccine candidate
-
0:19
vaxart continues to believe in the potential of its bivalent norovirus candidate
-
0:30
positive phase 2 topline results for bivalent norovirus candidate
-
0:37
vaxart expecting topline results from phase 1 norovirus trial in mid-2024
-
0:22
vaxart believes it has most advanced oral norovirus vaccine candidate in clinical development
-
0:19
vaxart's oral pill norovirus vaccine candidate has great potential
-
1:03
vaxart norovirus 2021
-
0:24
timeline nearing for phase 2 gi.1 norovirus challenge study
-
0:30
2023 was a transformational year for vaxart
-
0:21
significant second quarter progress
-
0:14
vaxart's norovirus vaccine trials: strong immune responses
-
59:30
dr. sean n. tucker: vaxart's oral covid-19 vaccine. hold the ice (and the needles)
-
1:00
vaxart | first & only covid oral tablet vaccine that has entered phase ii clinical trials
-
1:30
vaxart variants 2021
-
1:01
vaxart | duke-university-led study
-
0:59
vaccines against rotavirus and norovirus
-
0:18
making steady progress on vaxart's norovirus program